Lv31
250 积分 2026-08-27 加入
Emerging novel therapies for the treatment of hereditary haemorrhagic telangiectasia
3小时前
求助中
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB
3天前
已完结
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B
3天前
已完结
New Approaches to Chronic Hepatitis B
3天前
已完结
Advancements in therapeutic HBV vaccines: navigating the path toward functional cure
3天前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
4天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
5天前
已完结
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
5天前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
5天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
13天前
已完结
皖公网安备34019202002308
